4774-10-1

Basic information

• Product Name: 2-AMINO-3-METHOXYPYRAZINE
• Synonyms: 2-AMINO-3-METHOXYPYRAZINE;3-METHOXYPYRAZIN-2-YLAMINE;3-methoxypyrazin-2-amine;3-Methoxy-2-pyrazinamine
• CAS NO: 4774-10-1
• Molecular Formula: C₅H₇N₃O
• Molecular Weight: 125.13
• Product Categories: Amines;Pyrazines, Pyrimidines & Pyridazines;Pyrazines, Pyrimidines & Pyridazines
• Mol File: 4774-10-1.mol
• Article Data: 8

Chemical Properties

• Melting Point: 84-85℃
• Boiling Point: 241℃
• Flash Point: 100℃
• Appearance: /
• Density: 1.224
• Vapor Pressure: 0.037mmHg at 25°C
• Refractive Index: 1.567
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 3.49±0.10(Predicted)
• CAS DataBase Reference: 2-AMINO-3-METHOXYPYRAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-3-METHOXYPYRAZINE(4774-10-1)
• EPA Substance Registry System: 2-AMINO-3-METHOXYPYRAZINE(4774-10-1)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 4774-10-1(Hazardous Substances Data)

Usage

General Description

2-AMINO-3-METHOXYPYRAZINE is a chemical compound with the molecular formula C5H8N2O. It is a heterocyclic compound and belongs to the class of pyrazines. 2-AMINO-3-METHOXYPYRAZINE is characterized by its distinct odor, which is described as earthy, musty, and roasted. It is commonly found in food products such as roasted coffee, cocoa, and cooked meats, where it contributes to their aroma and flavor. 2-AMINO-3-METHOXYPYRAZINE is also used in the fragrance industry to impart earthy and roasted notes to perfumes and colognes. Additionally, it has potential applications in pharmaceuticals and as a chemical intermediate in organic synthesis. However, it is important to handle this compound with caution, as it may have toxic effects if ingested or inhaled in high concentrations.

InChI:InChI=1/C5H7N3O/c1-9-5-4(6)7-2-3-8-5/h2-3H,1H3,(H2,6,7)

Upstream product

• 67-56-1 methanol 
• 6863-73-6 3-chloropyrazin-2-amine 
• 5900-13-0 5-bromo-3-methoxypyrazin-2-amine 
• 180284-23-5 8-methoxytetrazolo<1,5-a>pyrazine 
• 3149-28-8 2-methoxypyrazine 
• 180284-25-7 N-(2-methoxy-3-pyrazinyl)triphenylphosphazene 

Downstream Products

• 146070-60-2 3-hydroxy-8-methoxy-2-phenylimidazo<1,2-a>pyrazine 
• 144294-16-6 ethyl 8-methoxy-2-phenylimidazo<1,2-a>pyrazine-3-carboxylate 
• 1447364-30-8 tert-butyl {1-[4-(8-methoxy-3-phenylimidazo[1,2-a]pyrazin-2-yl)phenyl]cyclobutyl}carbamate 
• 655-78-7 4-acetylamino-N-(3-methoxy-pyrazin-2-yl)-benzenesulfonamide 
• 152-47-6 Sulfalen 
• 1384274-35-4 N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophen-2-yl)propanamide 
• 1384274-36-5 N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(thiophen-2-yl)propanamide 
• 1384274-28-5 (E)-3-(5-bromothiophen-2-yl)-N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)acrylamide 
• 1384274-31-0 (E)-N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(3-nitrophenyl)acrylamide 
• 1384274-29-6 (E)-N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(4-nitrophenyl)acrylamide 
• 5900-13-0 5-bromo-3-methoxypyrazin-2-amine 
• 95516-10-2 4-acetylamino-N-(5-bromo-3-methoxy-pyrazin-2-yl)-benzenesulfonamide 
• 566203-88-1 2,3-dichloro-N-(3-methoxypyrazin-2-yl)benzenesulfonamide 
• 1384274-37-6 (E)-N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(thiophen-2-yl)acrylamide 

Relevant articles and documents

Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists

N-(5-Bromo-3-methoxypyrazin-2-yl)-5-chlorothiophene-2-sulfonamide 1 was identified as a hit in a CCR4 receptor antagonist high-throughput screen (HTS) of a subset of the AstraZeneca compound bank. As a hit with a lead-like profile, it was an excellent sta

Peptide deformylase inhibitors

The present invention relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods directed to bacterial infections and inhibition of bacterial peptide deformylase (PDF) activity.

PEPTIDE DEFORMYLASE INHIBITORS

The present invention relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods directed to bacterial infections and inhi-bition of bacterial peptide deformylase (PDF) activity